Arizona community receives grant to tackle opioid epidemic - Tucson News Now

Arizona community receives grant to tackle opioid epidemic

(Source: Tucson News Now) (Source: Tucson News Now)
TUCSON, AZ (Tucson News Now) -

A southern Arizona community is receiving a large grant to help tackle drug and opioid issues across the region.

Cochise County was awarded a $100,000 grant from the Center for Disease Control and Prevention to tackle the issue.

“Two people in Arizona die a day, because of opioids," said Carrie Langley, Director for Cochise Health and Social Services.

Langley said a large part of the problem is doctors over-prescribing and the grant will be used educate and train.

“We’ll be partnering with providers in the community to understand databases that are available and how to utilize those so they can see where their patients are accessing medications,” Langley said.

Carmen Arnold was just 12 years old when she got hooked on drugs like meth and speed pills.

“Every morning from the time I woke up until I went to bed  I was doing the drugs – it was a lot,” Arnold said. “At one point it was really, really tough. I became homeless because your friends give up on you. I hid it from my family. I didn’t reach out for help."

Arnold said help is exactly what drug users need to beat their addiction.

Langley said the Health Department plans to raise awareness about the electronic reporting system, which tells doctors if a patient has already been prescribed drugs elsewhere.

Arnold, who has been sober for 16 years, is hoping the grant will be the answer to clearing up substance abuse in the community.

“One person, if you help just one person, that’s how you get started,” she said.

MOBILE USERS: Download our Tucson News Now app for Apple and Android devices.

Copyright 2017 Tucson News Now. All rights reserved.

  • HealthHealthMore>>

  • Bayer to stop sales of birth control device tied to injuries

    Bayer to stop sales of birth control device tied to injuries

    Friday, July 20 2018 12:14 PM EDT2018-07-20 16:14:15 GMT
    Sunday, July 22 2018 11:06 PM EDT2018-07-23 03:06:42 GMT
    (Bayer Healthcare Pharmaceuticals via AP). FILE - This image provided by Bayer Healthcare Pharmaceuticals shows the birth control implant Essure. On Friday, July 20, 2018, the maker of the permanent contraceptive implant subject to thousands of injury ...(Bayer Healthcare Pharmaceuticals via AP). FILE - This image provided by Bayer Healthcare Pharmaceuticals shows the birth control implant Essure. On Friday, July 20, 2018, the maker of the permanent contraceptive implant subject to thousands of injury ...
    The maker of a permanent birth control implant said Friday it will stop selling the device in the U.S. at the end of the year.
    The maker of a permanent birth control implant said Friday it will stop selling the device in the U.S. at the end of the year.
  • Flint water crisis prompts call for more federal oversight

    Flint water crisis prompts call for more federal oversight

    Thursday, July 19 2018 2:46 PM EDT2018-07-19 18:46:02 GMT
    Sunday, July 22 2018 11:06 PM EDT2018-07-23 03:06:36 GMT
    A federal watchdog is calling on the Environmental Protection Agency to strengthen its oversight of state drinking water systems in the wake of the lead crisis in Flint, Michigan.
    A federal watchdog is calling on the Environmental Protection Agency to strengthen its oversight of state drinking water systems in the wake of the lead crisis in Flint, Michigan.
  • Simpler, one-dose treatment to prevent malaria relapse OK'd

    Simpler, one-dose treatment to prevent malaria relapse OK'd

    Friday, July 20 2018 6:04 PM EDT2018-07-20 22:04:04 GMT
    Sunday, July 22 2018 11:06 PM EDT2018-07-23 03:06:32 GMT
    (AP Photo/Kirsty Wigglesworth, File). FILE - This April 28, 2010, file photo shows the GlaxoSmithKline offices in London. On Friday, July 20, 2018, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a simpler, one-dose treatmen...(AP Photo/Kirsty Wigglesworth, File). FILE - This April 28, 2010, file photo shows the GlaxoSmithKline offices in London. On Friday, July 20, 2018, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a simpler, one-dose treatmen...
    U.S. regulators approve a simpler, one-dose treatment to prevent relapses of malaria.
    U.S. regulators approve a simpler, one-dose treatment to prevent relapses of malaria.
Powered by Frankly